6 results on '"Salomaa, Sisko"'
Search Results
2. The European initiative on low-dose risk research: from the HLEG to MELODI.
- Author
-
Belli M, Tabocchini MA, Jourdain JR, Salomaa S, and Repussard J
- Subjects
- European Union, Humans, Interdisciplinary Studies, Radiation Dosage, Radiation Exposure adverse effects, Radiation Injuries etiology, Biomedical Research trends, Radiation Injuries prevention & control, Radiation Protection methods, Research Design trends, Risk Assessment
- Abstract
The importance of low-dose risk research for radiation protection is now widely recognised. The European Commission (EC) and five European Union (EU) Member States involved in the Euratom Programme set up in 2008 a 'High Level and Expert Group on European Low Dose Risk Research' (HLEG) aimed at identifying research needs and proposing a better integration of European efforts in the field. The HLEG revised the research challenges and proposed a European research strategy based on a 'Multidisciplinary European LOw Dose Initiative' (MELODI). In April 2009, five national organisations, with the support of the EC, created the initial core of MELODI (http://www.melodi-online.eu) with a view to integrate the EU institutions with significant programmes in the field, while being open to other scientific organisations and stakeholders, and to develop an agreed strategic research agenda (SRA) and roadmap. Since then, open workshops have been organised yearly, exploring ideas for SRA implementation. As of October 2014, 31 institutions have been included as members of MELODI. HLEG recommendations and MELODI SRA have become important reference points in the radiation protection part of the Euratom Research Programme. MELODI has established close interactions through Memorandum of Understanding with other European platforms involved in radiation protection (Alliance, NERIS and EURADOS) and, together with EURADOS, with the relevant medical European Associations. The role of Joint Programming in priority setting, foreseen in the forthcoming EU Horizon 2020, calls for keeping MELODI an open, inclusive and transparent initiative, able to avoid redundancies and possible conflicts of interest, while promoting common initiatives in radiation protection research. An important issue is the establishment of a proper methodology for managing these initiatives, and this includes the set-up of an independent MELODI Scientific Committee recently extended to Alliance, NERIS and EURADOS, with the aim of identifying research priorities to suggest for the forthcoming Euratom research calls., (© The Author 2015. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com.)
- Published
- 2015
- Full Text
- View/download PDF
3. European low-dose radiation risk research strategy: future of research on biological effects at low doses.
- Author
-
Salomaa S, Averbeck D, Ottolenghi A, Sabatier L, Bouffler S, Atkinson M, and Jourdain JR
- Subjects
- Animals, Europe, Forecasting, Humans, Maximum Allowable Concentration, Radiation Dosage, Radiation Exposure adverse effects, Radiation Exposure prevention & control, Radiation Injuries etiology, Radiation Monitoring methods, Biomedical Research trends, Models, Biological, Radiation Injuries prevention & control, Radiation Protection methods, Radiobiology trends, Risk Assessment methods
- Abstract
In 2009, the European High Level and Expert Group identified key policy and scientific questions to be addressed through a strategic research agenda for low-dose radiation risk. This initiated the establishment of a European Research Platform, called MELODI (Multidisciplinary European Low Dose Research Initiative). In 2010, the DoReMi Network of Excellence was launched in the Euratom 7th Framework Programme. DoReMi has acted as an operational tool for the sustained development of the MELODI platform during its early years. A long-term Strategic Research Agenda for European low-dose radiation risk research has been developed by MELODI. Strategic planning of DoReMi research activities is carried out in close collaboration with MELODI. The research priorities for DoReMi are designed to focus on objectives that are achievable within the 6-y lifetime of the project and that are in areas where stimulus and support can help progress towards the longer-term strategic objectives., (© The Author 2014. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com.)
- Published
- 2015
- Full Text
- View/download PDF
4. Editorial. Non-DNA targeted effects.
- Author
-
Salomaa SI, Wright EG, Hildebrandt G, Kadhim MA, Little MP, Prise KM, and Belyakov OV
- Subjects
- Animals, DNA radiation effects, Dose-Response Relationship, Radiation, Humans, Models, Biological, Radiation Injuries etiology, Radiation Protection, Bystander Effect, Genomic Instability, Radiation Effects, Radiation, Ionizing, Risk Assessment
- Published
- 2010
- Full Text
- View/download PDF
5. Application of radiation omics in the development of adverse outcome pathway networks: an example of radiation-induced cardiovascular disease.
- Author
-
Azimzadeh, Omid, Moertl, Simone, Ramadan, Raghda, Baselet, Bjorn, Laiakis, Evagelia C., Sebastian, Soji, Beaton, Danielle, Hartikainen, Jaana M., Kaiser, Jan Christian, Beheshti, Afshin, Salomaa, Sisko, Chauhan, Vinita, and Hamada, Nobuyuki
- Subjects
RADIOBIOLOGY ,ULTRAVIOLET radiation ,IONIZING radiation ,CARDIOVASCULAR diseases ,RADIATION ,BIOLOGICAL systems ,PREDICTIVE validity - Abstract
Epidemiological studies have indicated that exposure of the heart to doses of ionizing radiation as low as 0.5 Gy increases the risk of cardiac morbidity and mortality with a latency period of decades. The damaging effects of radiation to myocardial and endothelial structures and functions have been confirmed radiobiologically at high dose, but much less are known at low dose. Integration of radiation biology and epidemiology data is a recommended approach to improve the radiation risk assessment process. The adverse outcome pathway (AOP) framework offers a comprehensive tool to compile and translate mechanistic information into pathological endpoints which may be relevant for risk assessment at the different levels of a biological system. Omics technologies enable the generation of large volumes of biological data at various levels of complexity, from molecular pathways to functional organisms. Given the quality and quantity of available data across levels of biology, omics data can be attractive sources of information for use within the AOP framework. It is anticipated that radiation omics studies could improve our understanding of the molecular mechanisms behind the adverse effects of radiation on the cardiovascular system. In this review, we explored the available omics studies on radiation-induced cardiovascular disease (CVD) and their applicability to the proposed AOP for CVD. The results of 80 omics studies published on radiation-induced CVD over the past 20 years have been discussed in the context of the AOP of CVD proposed by Chauhan et al. Most of the available omics data on radiation-induced CVD are from proteomics, transcriptomics, and metabolomics, whereas few datasets were available from epigenomics and multi-omics. The omics data presented here show great promise in providing information for several key events (KEs) of the proposed AOP of CVD, particularly oxidative stress, alterations of energy metabolism, extracellular matrix (ECM), and vascular remodeling. The omics data presented here shows promise to inform the various levels of the proposed AOP of CVD. However, the data highlight the urgent need of designing omics studies to address the knowledge gap concerning different radiation scenarios, time after exposure, and experimental models. This review presents the evidence to build a qualitative omics-informed AOP and provides views on the potential benefits and challenges in using omics data to assess risk-related outcomes. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
6. State of the art in research into the risk of low dose radiation exposure--findings of the fourth MELODI workshop.
- Author
-
Salomaa, Sisko, Prise, Kevin M, Atkinson, Michael J, Wojcik, Andrze J., Auvinen, Anssi, Grosche, Bernd, Sabatier, Laure, Jourdain, Jean-René, Salminen, Eeva, Baatout, Sarah, Kulka, Ulrike, Rabus, Hans, Blanchardon, Eric, Averbeck, Dietrich, and Weiss, Wolfgang
- Subjects
- *
SCIENTISTS , *ADULT education workshops , *RADIATION protection , *RISK assessment , *CONFERENCES & conventions - Abstract
The fourth workshop of the Multidisciplinary European Low Dose Initiative (MELODI) was organised by STUK-Radiation and Nuclear Safety Authority of Finland. It took place from 12 to 14 September 2012 in Helsinki, Finland. The meeting was attended by 179 scientists and professionals engaged in radiation research and radiation protection. We summarise the major scientific findings of the workshop and the recommendations for updating the MELODI Strategic Research Agenda and Road Map for future low dose research activities. [ABSTRACT FROM AUTHOR]
- Published
- 2013
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.